Bayer invests 2 billion euros in the production of medicines

German drugmaker Bayer said it will invest about 2 billion euros ($2.23 billion) in pharmaceutical manufacturing sites over the next three years, mainly to support the production of biotech drugs, as well as cell and gene therapies.

Share this post:

Share on facebook
Share on twitter
Share on pinterest
Share on whatsapp
Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner